≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Benign neoplasm: Orbit, unspecified

DOID EFO Endpoint Browser PheWeb

CD2_BENIGN_ORBIT_NOS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D31.6&
  • Hospital discharge: ICD-9 — 2241
  • Hospital discharge: ICD-8 — 22405
  • Cause of death: ICD-10 — D31.6&
  • Cause of death: ICD-9 — 2241
  • Cause of death: ICD-8 — 22405

2 out of 7 registries used, show all original rules.

217

4. Check minimum number of events

None

217

5. Include endpoints

None

217

6. Filter based on genotype QC (FinnGen only)

217

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D31
Name in latin
Neoplasma benignum orbitae non specificatum

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1703 988 701
Only index persons 1480 873 607
Unadjusted period prevalence (%)
Whole population 0.02 0.03 0.02
Only index persons 0.03 0.03 0.02
Median age at first event (years)
Whole population 50.29 50.56 49.71
Only index persons 49.65 50.35 48.65

-FinnGen-

Key figures

All Female Male
Number of individuals 217 144 73
Unadjusted period prevalence (%) 0.04 0.05 0.03
Median age at first event (years) 54.74 52.89 58.38

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
187
Matched controls
1870
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
+∞
210.2
160
*
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
499.5
41.9
40
*
CAA30
NOMESCO Finland
Biopsy of orbit
+∞
30.0
28
*
H05.2
ICD-10 Finland
Exophthalmic conditions
+∞
18.0
17
*
22405
ICD-8 Finland
Benign neoplasm of eye, Orbitae
+∞
16.9
16
*
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
173.9
15.7
16
*
2241A
ICD-9 Finland
Benign neoplasm of eye, Orbit
+∞
14.8
14
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.9
14.6
38
67
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
81.2
13.8
15
*
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
+∞
13.7
13
*
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
150.5
13.6
14
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
13.6
13.5
23
19
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.7
11.0
54
185
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
23.1
10.9
15
7
CAB10
NOMESCO Finland
Lateral orbitotomy with excision of lesion
+∞
10.5
10
*
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
58.1
9.8
11
*
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
58.1
9.8
11
*
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
+∞
9.4
9
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
5.9
9.4
26
50
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
8.0
8.7
19
26
XCK00
NOMESCO Finland
Perimetry
4.7
8.6
29
70
C69.60
ICD-10 Finland
Malignant tumor in orbit without histology
+∞
8.4
8
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
18.2
8.2
12
7
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
35.0
8.2
10
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.4
7.8
95
559
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.1
7.7
30
83
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
83.3
7.5
8
*
H05.9
ICD-10 Finland
Disorder of orbit, unspecified
+∞
7.3
7
*
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
7.3
7
*
WX002
NOMESCO Finland
Sedation and analgesia
2.7
6.8
50
221
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
23.5
6.7
9
*
CS494
NOMESCO Finland
Other visual field testing
8.6
6.4
13
16
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
6.4
63
325
CBA10
NOMESCO Finland
Biopsy of eyelid
18.8
6.3
9
5
XCK10
NOMESCO Finland
Photography of fundus of eye
3.3
6.2
31
106
AA1AD
NOMESCO Finland
CT of head and brain
2.4
6.1
61
313
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
10.5
6.1
11
11
XCD10
NOMESCO Finland
Electrophysiological examination of eye
7.7
6.0
13
18

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
37
145
2.87
7.06
1.3
1.3
—
—
—
0
0
144
1030
2.18
6.79
7.8
8.7
4.2
4.1
e9/l
0.14
120
917
127
898
2.00
5.78
4.9
5.4
2.2
1.9
e9/l
0.36
110
810
115
786
1.99
5.77
5.7
6.2
1.2
1.2
mmol/l
1.10
105
711
124
871
1.99
5.74
4.9
5.3
0.6
0.6
e9/l
0.27
106
770
124
874
1.98
5.65
5.0
5.3
0.0
0.0
e9/l
0.06
106
772
142
1068
1.95
5.14
4.9
5.1
6.6
6.7
mmol/l
0.17
137
979
125
903
1.91
5.09
5.2
5.5
0.2
0.2
e9/l
0.46
110
812
205
1801
3.50
4.77
16.0
14.2
22.0
22.7
mg/l
0.10
178
1409
85
560
1.85
4.47
6.5
5.4
—
—
—
0
0
117
854
1.80
4.37
7.2
7.2
1.2
1.2
mmol/l
0.31
103
717
10
22
4.72
4.35
1.1
1.0
—
—
—
0
0
110
790
1.80
4.32
5.8
5.5
0.8
0.7
%
0.93
104
740
112
812
1.78
4.23
5.8
5.5
3.2
2.8
%
0.89
106
760
115
841
1.78
4.21
5.9
5.5
26.3
27.6
%
0.65
108
789
39
200
2.16
4.16
1.3
1.2
—
—
—
0
0
114
834
1.77
4.15
5.5
5.4
58.1
57.7
%
0.11
106
787
112
817
1.77
4.11
6.2
5.8
8.9
8.5
%
0.65
106
773
99
698
1.77
4.07
7.2
8.9
1.3
1.2
inr
0.48
21
212
98
694
1.75
3.94
2.5
2.0
—
—
—
0
0
41
219
2.08
3.93
1.3
1.3
480.0
546.4
titre
—
9
53
162
1326
1.87
3.93
3.9
3.9
12.5
11.6
mm/h
0.41
152
1205
69
453
1.77
3.54
4.8
6.3
—
—
—
0
0
115
875
1.67
3.40
4.6
4.0
0.0
0.0
estimate
0.00
14
176
12
37
3.37
3.39
1.0
1.1
—
—
—
0
0
99
726
1.67
3.36
2.1
1.9
94.7
95.8
pmol/l
0.08
51
352
151
1238
1.72
3.33
4.5
4.6
—
—
—
0
0
115
888
1.63
3.11
6.1
5.4
0.0
0.0
estimate
0.00
14
175
11
34
3.35
3.10
1.2
1.2
2.2
4.4
u/ml
—
6
16
116
900
1.62
3.06
4.7
4.0
0.0
0.0
estimate
0.00
14
173
20
88
2.40
3.04
9.6
10.9
24.8
24.6
mmol/l
0.17
20
81
36
203
1.93
2.96
7.3
10.1
0.5
1.3
mmol/l
1.43
29
163
187
1653
1.95
2.95
5.5
4.7
1.7
1.9
mu/l
1.54
173
1498
8
17
4.84
2.95
1.1
1.1
—
—
—
0
0
25
125
2.13
2.84
1.3
1.4
—
—
—
0
0
60
402
1.68
2.79
6.1
3.9
—
—
—
0
0
78
559
1.62
2.79
2.0
2.4
—
—
—
0
0
160
1361
1.67
2.78
4.6
4.0
14.7
14.8
pmol/l
0.18
149
1215
201
1832
2.32
2.77
19.2
16.6
139.5
139.6
mmol/l
0.33
201
1777
59
397
1.67
2.69
2.4
1.8
1.4
1.2
mg/l
0.15
46
306
7
15
4.78
2.62
1.3
1.0
—
—
—
0
0
7
15
4.78
2.62
3.6
3.0
—
—
—
0
0
63
435
1.63
2.60
1.5
1.5
23.6
21.8
nmol/l
0.37
58
361
143
1202
1.56
2.43
6.4
4.8
—
2915.6
—
0
23
42
625
0.59
2.40
3.0
2.9
—
—
—
0
0
97
756
1.51
2.31
5.7
4.6
36.0
35.7
g/l
0.16
87
706
9
29
3.19
2.25
1.2
1.3
—
—
—
0
0
204
1896
2.27
2.23
11.0
10.0
23.7
25.0
u/l
0.87
198
1823
6
14
4.37
2.16
1.2
1.0
—
—
—
0
0
210
1993
2.66
2.15
24.9
20.6
133.3
134.5
g/l
0.64
210
1961
210
1992
2.68
2.14
24.8
20.5
7.0
6.7
e9/l
0.74
203
1937
210
1991
2.70
2.14
24.8
20.5
4.5
4.5
e12/l
0.17
203
1935
210
1991
2.70
2.14
24.7
20.4
90.5
91.0
fl
0.87
210
1960
210
1991
2.70
2.14
24.7
20.4
30.1
30.3
pg
0.79
210
1960
15
69
2.26
2.10
3.7
3.6
—
—
—
0
0
65
478
1.51
1.99
4.0
4.2
—
—
—
0
0
70
523
1.50
1.99
3.5
3.9
7.4
7.4
ph
—
7
101
7
21
3.41
1.98
1.1
1.4
—
—
—
0
0
157
1381
1.49
1.88
7.5
7.2
75.0
76.7
u/l
0.26
151
1290
48
335
1.56
1.86
4.9
3.8
22.6
253.4
ng/l
1.60
34
270
179
1621
1.60
1.85
19.6
15.1
39.3
39.8
%
0.36
138
1191
43
294
1.58
1.82
1.7
1.6
—
—
—
0
0
7
23
3.11
1.81
2.3
2.0
—
—
—
0
0
169
1514
1.53
1.81
22.4
17.8
332.6
332.2
g/l
0.26
169
1504
11
47
2.41
1.81
1.6
3.1
—
—
—
0
0
77
601
1.44
1.72
4.1
3.3
2.3
2.4
mmol/l
0.78
67
519
143
1246
1.43
1.72
4.0
3.8
—
—
—
0
0
66
502
1.45
1.69
3.5
2.9
0.4
0.6
e6/l
0.55
41
375
6
19
3.22
1.67
1.5
3.7
—
—
—
0
0
15
77
2.02
1.63
1.5
1.8
—
—
—
0
0
5
14
3.63
1.62
5.8
1.9
55.0
57.0
%
—
5
8
5
14
3.63
1.62
1.0
1.1
—
—
—
0
0
24
145
1.74
1.62
6.9
3.3
—
—
—
0
0
65
498
1.44
1.59
3.5
2.8
—
—
—
0
0
22
131
1.76
1.56
9.7
9.1
—
—
—
0
0
0
44
0.00
1.53
0.0
1.1
—
—
—
0
0
12
59
2.09
1.46
1.8
1.7
—
—
—
0
0
7
28
2.55
1.46
1.3
1.2
—
—
—
0
0
112
953
1.36
1.45
6.5
6.1
10.9
10.7
umol/l
0.09
107
896
72
571
1.39
1.44
5.1
3.3
—
—
—
0
0
166
1507
1.43
1.43
19.1
17.3
13.6
13.7
%
0.24
166
1477
34
233
1.54
1.43
1.4
1.3
—
—
—
0
0
12
60
2.06
1.41
3.2
2.3
1150.9
8556.8
u/l
—
6
20
187
1739
1.54
1.40
4.4
4.4
5.9
5.9
mmol/l
0.13
168
1585
93
772
1.36
1.40
7.3
9.7
0.0
0.0
e9/l
0.61
68
632
25
160
1.64
1.39
4.0
4.0
—
—
—
0
0
14
75
1.93
1.38
3.6
3.6
—
—
—
0
0
180
1663
1.48
1.37
3.9
4.0
1.3
1.3
mmol/l
0.30
161
1520
187
1742
1.53
1.36
4.4
4.4
4.7
4.7
mmol/l
0.12
176
1606
190
1776
1.56
1.35
5.2
4.9
2.8
2.7
mmol/l
0.12
178
1623
0
38
0.00
1.35
0.0
2.1
—
—
—
0
0
51
385
1.42
1.34
6.3
4.5
1.0
1.0
kg/l
—
7
59
10
48
2.14
1.30
3.5
5.2
73.3
72.3
mg/l
—
10
38
10
48
2.14
1.30
3.5
5.2
48.1
24.7
mg/l
—
10
38
18
108
1.73
1.27
2.6
2.3
10.0
13.2
nmol/l
0.78
13
101
38
275
1.46
1.25
2.7
3.4
0.8
0.8
mmol/l
0.05
33
255
31
215
1.52
1.25
1.7
1.5
—
—
—
0
0
185
1729
1.47
1.22
4.4
4.4
1.5
1.5
mmol/l
0.54
170
1589
83
691
1.33
1.19
4.1
3.9
20.8
43.9
ng/l
1.94
59
480
198
1880
1.61
1.16
15.5
13.3
—
—
—
0
0
11
58
1.94
1.14
1.5
2.1
37.7
39.2
g/l
0.39
11
49
176
1642
1.38
1.06
5.8
5.7
39.3
39.8
mmol/mol
0.29
165
1528
7
34
2.09
1.04
3.6
1.6
—
—
—
0
0
32
234
1.43
1.01
33.2
22.3
—
1.3
—
0
31
38
287
1.39
1.01
1.2
1.2
12.8
38.6
iu/ml
—
10
84
18
116
1.60
1.00
2.9
2.5
—
—
—
0
0
6
27
2.26
0.94
1.2
1.2
—
—
—
0
0
6
29
2.10
0.90
1.7
1.4
—
—
—
0
0
25
179
1.45
0.89
3.7
3.9
2.3
44.1
ug/l
0.58
18
150
6
30
2.03
0.87
1.0
1.3
—
—
—
0
0
15
96
1.60
0.87
1.1
1.2
52.1
216.1
u/ml
2.42
15
87
14
88
1.63
0.86
12.1
15.2
—
—
—
0
0
76
651
1.26
0.84
4.4
3.6
62.1
97.1
e6/l
0.41
43
461
26
190
1.42
0.84
2.3
1.7
—
—
—
0
0
36
279
1.35
0.83
1.3
1.3
1.2
11.7
u/ml
2.34
11
106
32
244
1.37
0.81
3.1
2.3
22.1
22.6
%
0.06
27
206
15
98
1.57
0.81
5.5
5.7
24.8
24.7
mmol/l
0.05
15
98
18
123
1.51
0.80
3.7
7.9
—
—
—
0
0
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
0
25
0.00
0.79
0.0
1.4
—
0.4
—
0
20
66
561
1.25
0.77
3.5
3.0
24.0
160.9
e6/l
0.63
41
433
6
34
1.79
0.77
1.3
1.4
—
—
—
0
0
9
53
1.73
0.76
1.0
1.4
—
—
—
0
0
5
24
2.11
0.75
1.2
1.1
—
—
—
0
0
10
60
1.70
0.73
4.1
3.2
3.7
3.9
mmol/l
—
10
53
25
187
1.38
0.72
1.2
1.3
—
—
—
0
0
19
135
1.45
0.72
1.8
4.6
0.0
0.3
%
—
5
37
43
350
1.29
0.71
2.1
1.9
—
—
—
0
0
5
26
1.94
0.71
1.0
1.2
—
—
—
0
0
53
446
1.25
0.67
2.9
2.0
2.8
3.0
mg/l
0.21
43
379
20
146
1.41
0.66
1.9
4.5
0.6
1.0
%
—
5
41
40
326
1.28
0.66
1.7
1.6
1144.0
1202.2
nmol/l
0.15
31
238
88
783
1.21
0.66
3.4
2.6
96.8
108.6
ug/l
0.44
83
710
18
129
1.43
0.66
2.2
4.5
1.2
0.5
%
—
5
26
8
49
1.66
0.63
2.4
2.7
1.4
1.6
mg/l
—
8
44
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
0
20
0.00
0.60
0.0
4.7
—
—
—
0
0
60
519
1.22
0.59
3.1
2.9
7.7
7.5
mmol/l
0.13
51
438
16
115
1.42
0.58
1.6
1.5
—
—
—
0
0
6
35
1.73
0.58
1.2
1.2
3.1
3.8
mmol/l
—
6
30
8
54
1.50
0.58
1.3
1.2
—
—
—
0
0
56
483
1.21
0.57
3.8
3.1
1276.6
209.0
mg/l
0.42
31
308
26
205
1.30
0.56
1.9
1.9
—
—
—
0
0
12
82
1.49
0.55
2.4
1.9
—
—
—
0
0
9
61
1.50
0.54
1.4
1.9
1075.9
360.2
ug/l
—
9
55
41
344
1.24
0.54
3.8
2.7
2.4
2.5
mmol/l
0.09
34
298
59
515
1.20
0.53
1.4
1.5
—
—
—
0
0
7
110
0.62
0.49
1.4
1.5
—
—
—
0
0
7
46
1.54
0.49
1.7
2.2
—
—
—
0
0
15
111
1.38
0.48
3.4
3.1
—
7.4
—
0
18
17
129
1.34
0.47
2.2
4.7
0.0
0.3
%
—
5
30
11
77
1.45
0.46
1.1
1.2
—
—
—
0
0
15
112
1.36
0.46
3.4
3.1
5.2
5.0
kpa
0.39
15
105
58
513
1.18
0.45
4.0
3.9
11.0
11.9
mg/mmol
0.04
32
321
12
86
1.42
0.45
2.7
2.4
1.1
1.2
%
0.05
12
86
26
212
1.26
0.45
1.6
1.4
—
—
—
0
0
5
32
1.58
0.42
1.2
1.2
—
—
—
0
0
31
260
1.22
0.42
1.7
2.1
—
—
—
0
0
13
171
0.74
0.41
1.5
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
5.6
—
—
—
0
0
18
142
1.29
0.40
2.2
2.9
75.7
72.7
e9/l
0.13
13
110
42
366
1.18
0.39
1.4
1.7
407.1
458.6
pmol/l
0.65
36
302
32
371
0.84
0.36
2.0
2.8
487.8
539.5
mosm/kgh2o
0.69
26
317
27
230
1.20
0.33
2.7
2.1
80.8
129.4
ug/g
0.79
20
176
19
156
1.24
0.32
1.4
1.4
—
—
—
0
0
20
166
1.23
0.31
1.3
1.4
—
—
—
0
0
7
54
1.31
0.30
1.4
1.2
—
—
—
0
0
13
102
1.29
0.30
1.2
1.2
—
—
—
0
0
12
151
0.78
0.29
4.3
4.3
—
—
—
0
0
12
95
1.28
0.27
1.8
3.7
—
—
—
0
0
12
146
0.81
0.23
1.6
1.2
—
—
—
0
0
31
278
1.13
0.22
2.7
3.1
0.9
0.8
ug/l
0.29
19
181
5
42
1.19
0.21
1.2
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.6
—
145.1
—
0
11
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
4.0
—
—
—
0
0
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
7
60
1.17
0.18
2.1
2.6
—
—
—
0
0
7
61
1.15
0.17
1.1
1.1
—
—
—
0
0
8
70
1.15
0.16
1.0
1.1
—
—
—
0
0
48
510
0.92
0.15
2.9
3.7
—
—
—
0
0
22
199
1.12
0.14
1.6
1.7
—
—
—
0
0
5
61
0.82
0.08
1.2
1.4
—
—
—
0
0
13
117
1.12
0.08
1.1
1.2
—
—
—
0
0
35
365
0.95
0.06
1.5
1.3
2.4
2.5
g/l
0.08
24
210
17
159
1.08
0.05
6.2
3.6
—
—
—
0
0
48
493
0.97
0.04
7.0
4.3
0.0
0.0
estimate
0.00
14
172
37
382
0.96
0.04
2.4
2.5
7.2
5.4
e6/l
0.30
31
340
41
398
1.04
0.04
1.2
1.2
1.0
1.0
u/ml
—
7
100
48
489
0.98
0.02
1.8
1.7
1.3
1.3
mmol/l
0.20
42
408
10
96
1.04
0.00
1.6
2.5
—
—
—
0
0
13
135
0.96
0.00
2.1
3.2
—
—
—
0
0
41
408
1.01
0.00
2.4
4.6
—
—
—
0
0
51
512
0.99
0.00
4.2
4.1
—
—
—
0
0
0
7
0.00
0.00
0.0
6.0
—
—
—
0
0
6
65
0.92
0.00
1.2
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
0.00
12.2
9.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
6
66
0.91
0.00
1.2
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
6
65
0.92
0.00
1.2
1.4
—
—
—
0
0
6
65
0.92
0.00
1.2
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
5.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_ORBIT_NOS and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_ORBIT_NOS 1.274 [1.0, 1.63] 0.051
Birth year 0.99 [0.98, 1.0] 0.051

During the follow-up period (1.1.1998 — 31.12.2019), 108 out of 648 females with CD2_BENIGN_ORBIT_NOS died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_ORBIT_NOS 1.337 [1.0, 1.79] 0.053
Birth year 0.984 [0.97, 0.99] 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 90 out of 444 males with CD2_BENIGN_ORBIT_NOS died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_ORBIT_NOS.

N-year risk Females Males
1 0.107% 0.224%
5 0.624% 1.468%
10 1.459% 3.587%
15 2.954% 6.69%
20 5.353% 11.526%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_ORBIT_NOS – Benign neoplasm: Orbit, unspecified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data